Carcino Embryonic Antigen (CEA)
CEA is a protein that can be elevated in certain cancers, especially colorectal cancer. This blood test is primarily used to monitor cancer treatment and detect recurrence rather than for initial screening.
- DHA-licensed lab
- Includes Doctor Consultation
- Physician-reviewed
- Same Day Collection
24 hours
Turnaround
Blood
Sample
What the Carcino Embryonic Antigen (CEA) test tells you
Carcinoembryonic antigen, usually shortened to CEA, is a sugar-coated protein that helps cells stick to one another. It is made in quantity by the developing gut before birth, and only in traces by healthy adult tissue. Some tumours switch the gene back on, so the protein reappears in the bloodstream where it can be measured. That is the whole basis of the test: it does not look for cancer cells directly, but for a substance that certain cancers release.
CEA is most closely associated with cancers of the colon and rectum, and it is here that it earns its place in routine care. It is measured before surgery to establish a starting point, then repeated at intervals afterwards. A value that falls after treatment and stays down is reassuring; one that climbs steadily across successive samples prompts imaging to look for disease that has returned. Because the direction of travel over several samples carries far more information than any single reading, results are always read in sequence rather than in isolation.
The protein is not exclusive to cancer. Smoking raises it, as do inflammatory bowel disease, chronic liver disease, pancreatitis and several benign lung conditions. Equally, a substantial share of colorectal tumours never produce much CEA at all, so an unremarkable result does not rule cancer out. For these reasons CEA is not used to screen people who have no symptoms and no diagnosis; it belongs to the follow-up of a known condition, alongside scans, endoscopy and your doctor's assessment.
Most commonly used to monitor treatment response in colorectal cancer patients and for early detection of recurrence after surgery.
- Tracking treatment response
Repeated during and after treatment for colorectal cancer, CEA indicates whether tumour burden is falling. A steady decline supports that the treatment is working.
- Watching for recurrence
After surgery intended to cure, serial measurements can flag returning disease before any symptom appears, prompting earlier imaging.
- Setting a baseline
A value taken before treatment shows whether this particular tumour secretes CEA at all, which decides how useful later readings will be.
- Clarifying uncertain scans
When imaging findings are ambiguous, the trend in CEA across successive samples adds context to the decision about what to do next.
Reasons your doctor may request the Carcino Embryonic Antigen (CEA) test
Your doctor may order this test for any of the reasons below. Some are routine checks, others follow specific symptoms or an earlier result.
Colorectal cancer follow-up
- You are being treated for colorectal cancer and your oncologist wants to follow the response.
- You have completed surgery for bowel cancer and are in a structured follow-up programme.
Suspected recurrence
- Imaging has raised a question about recurrence and your doctor wants supporting information.
Choosing a marker to follow
- You are being assessed for a cancer of the pancreas, stomach, lung or breast where CEA is one of several markers considered.
- Your specialist is deciding which tumour marker is worth following in your particular case.
A result in the Normal band, 0 to 3 ng/mL, is what most healthy non-smokers show and carries no meaning of its own; a substantial share of colorectal tumours never release much CEA, so it is not reassurance by itself. A result in the Borderline band, 3.1 to 5 ng/mL, is mildly raised and can occur simply because you smoke. A result in the High band, 5.1 to 1000 ng/mL, needs context: inflammatory bowel disease, chronic liver disease, pancreatitis, peptic ulcer disease and benign lung conditions all lift it with no cancer present. Because CEA is used to follow a cancer already diagnosed, the direction of travel across successive samples matters far more than a single reading, and follow-up samples should ideally be run by the same laboratory. Your doctor interprets it with imaging, examination, your smoking history and how you feel.
Medically reviewed by Dr Nirupama Sabhapathy
Ranges are a guide: your physician interprets your result alongside your symptoms and history.
What a higher result can point to
- Colorectal cancer, particularly when disease is widespread rather than confined.
- Cancers of the pancreas, stomach, lung, breast, thyroid or ovary.
- Regular cigarette smoking, which lifts CEA in people with no cancer at all.
- Inflammatory bowel disease such as ulcerative colitis or Crohn's disease.
- Chronic liver disease, pancreatitis or peptic ulcer disease.
- Benign lung conditions including chronic bronchitis and emphysema.
These are possibilities, not diagnoses. A single value outside the reference range is interpreted alongside your symptoms, history and other tests: your doctor decides what it means for you.
What this test cannot tell you
- A low or undetectable CEA does not exclude cancer, because many tumours never release it.
- Non-cancerous conditions and smoking raise CEA, so a single high value is not evidence of malignancy.
- Results from different assay platforms are not interchangeable, so follow-up samples should ideally be run by the same laboratory.
- It is not a screening test and should not be ordered to look for cancer in someone who is well.
Risks of the blood draw
- Mild bruising or brief soreness where the needle went in.
- Occasional lightheadedness, which settles after a few minutes of rest.
- Bleeding or infection at the site, which is rare with sterile single-use equipment.
- 1CEA is a monitoring tool for a cancer already diagnosed, not a way of finding one.
- 2The trend across repeated samples matters far more than any single result.
- 3Smoking, bowel inflammation and liver disease can all lift the value without cancer being present.
- 4An undetectable result is expected in most healthy adults and carries no meaning on its own.
- 5Your oncologist interprets CEA together with imaging, examination and how you feel.
Carcino Embryonic Antigen (CEA) also comes in these focused packages, which pair it with the tests usually read alongside it.
- Tumour MarkersCA-19-9
CA-19-9 is a tumour marker commonly associated with pancreatic cancer. It can also be elevated in other gastrointestinal cancers and some…
75View - Tumour MarkersCA-15-3
CA-15-3 is a tumour marker primarily used to monitor breast cancer treatment and detect recurrence. Rising levels may indicate disease progression. A…
75View - Tumour MarkersAlpha Fetoprotein (AFP)
Alpha-Fetoprotein (AFP) is a protein produced mainly by the fetal liver. Elevated levels in adults may indicate certain liver conditions or be used…
70View - Stool StudiesOccult Blood (Fecal Occult Blood/FOB)
This stool test detects hidden (occult) blood that is not visible to the naked eye. It is a key screening tool for colorectal cancer and can also…
60View
Frequently Asked Questions
Everything you need to know about the Carcino Embryonic Antigen (CEA) test. Can't find what you're looking for?
Talk to our team→Our laboratory reports 0 to 3 ng/mL as normal, which is what most healthy non-smokers show. A result of 3.1 to 5 ng/mL is borderline and can occur simply because you smoke. Above 5 ng/mL is reported as high and needs clinical context, since several non-cancerous conditions also raise it.
Regular smoking is the commonest cause. Inflammatory bowel disease such as ulcerative colitis or Crohn's disease, chronic liver disease, pancreatitis, peptic ulcer disease and benign lung conditions such as chronic bronchitis and emphysema can all lift CEA with no cancer present, which is why a single high value is not evidence of malignancy.
CEA is best known in colorectal cancer, where it tends to be higher when the disease is widespread rather than confined. Cancers of the pancreas, stomach, lung, breast, thyroid and ovary can also raise it. Many tumours release little or none, so CEA is used to follow a cancer already diagnosed rather than to find one.
It is measured repeatedly to follow response to treatment and to help pick up a recurrence after surgery. What matters is the direction of travel across successive samples, not any single reading. Your oncologist sets how often it is checked and reads it with imaging, examination and how you feel.
Results from different assay platforms are not interchangeable, so a change between two laboratories may reflect the method rather than your disease. Keeping the same laboratory and, where practical, a similar time of day makes the trend reliable. Bring previous CEA reports so the readings can be plotted together.
No. It is neither sensitive nor specific enough for that job: many early bowel cancers make little CEA, and several harmless conditions raise it. Bowel cancer screening is done with stool testing and colonoscopy; CEA has its role after a diagnosis has been made.
Not on its own. Small fluctuations arise from assay variation, smoking and intercurrent illness. Doctors look for a rise that is sustained across repeat samples before acting, and confirm any concern with imaging.
Yes. Regular smokers tend to run higher CEA than non-smokers with no cancer present, and the value often drifts down after quitting. This is one reason your doctor asks about tobacco use when reading the report.
Some tumours simply do not produce this protein. If your pre-treatment value was not raised, CEA will not be a useful marker to follow in your case, and your team will monitor you with imaging and other tests instead.
No. No fasting is needed and you can drink water freely. Tell the laboratory if you smoke, since tobacco raises CEA and your doctor will want to allow for it.
The CEA test is AED 80, including a physician-reviewed report, with results usually within 24 hours. Home collection anywhere in Dubai is free when your order reaches AED 300 or includes a package; below that, a AED 100 home collection fee applies (AED 50 for a lab walk-in).